Ocular Therapeutix
Trade Ocular Therapeutix 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About OCUL
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.
OCUL Key Statistics
Stock Snapshot
The current Ocular Therapeutix(OCUL) stock price is $7.75, with a market capitalization of 1.7B. The stock trades at a price-to-earnings (P/E) ratio of -5.41.
As of 2026-02-22, Ocular Therapeutix(OCUL) stock has fluctuated between $6.92 and $8.00. The current price stands at $7.75, placing the stock +12.0% above today's low and -3.1% off the high.
The Ocular Therapeutix(OCUL)'s current trading volume is 13M, compared to an average daily volume of 10.86M.
During the past year, Ocular Therapeutix(OCUL) stock moved between $5.79 at its lowest and $16.44 at its peak.
During the past year, Ocular Therapeutix(OCUL) stock moved between $5.79 at its lowest and $16.44 at its peak.
OCUL News
Ocular Therapeutix Inc. (NASDAQ:OCUL) shares are down during Tuesday's premarket session following a significant announcement regarding their Axpaxli treatment...
Ocular Therapeutix reported fourth-quarter 2025 revenue of US$13.25 million and a net loss of US$64.65 million, and filed an US$8.29 million shelf registration...
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.